Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02455050 · ClinicalTrials.gov registry record · Phase 3
A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief
A Phase 3 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 3
- Development phase
- 79
- Enrollment target
NCT02455050 is a Phase 3 study that has completed, run by Allergan. The registered enrollment target is 79 participants.
The verdict
NCT02455050, a Phase 3 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 79 participants
- Enrollment target
Study Summary
A study to evaluate the tolerability and acceptability of an investigational eye drop formulation in patients with Dry Eye Disease.
Interventions
- DRUG Carboxymethylcellulose Sodium Based Eye Drops
- DRUG Systane® Gel Drops
- DRUG Genteal® Lubricant Gel Drops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2014-12 |
| Est. Completion | 2015-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02455050
The ClinicalTrials.gov registry entry for NCT02455050 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Carboxymethylcellulose Sodium Based Eye Drops is the first listed.
NCT02455050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02455050 about?
NCT02455050 is a clinical study titled "A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief". A study to evaluate the tolerability and acceptability of an investigational eye drop formulation in patients with Dry Eye Disease.
What is the current status of trial NCT02455050?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 79 participants. The study started on 2014-12. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02455050?
The interventions under investigation include: Carboxymethylcellulose Sodium Based Eye Drops (DRUG), Systane® Gel Drops (DRUG), Genteal® Lubricant Gel Drops (DRUG).
Who is sponsoring clinical trial NCT02455050?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.